RMG Research
is now available
on iPhone and iPad.
Latest Research
Acron: Better from 2014, Much Undervalued
29.04.2013
17.04.2013
11.04.2013
rmg@rmg.ruTel.: +7 495 258 62 62Fax: +7 495 258 62 26
Please read Legal information carefully before using this site. Information and services described on this site may not be available for residents of certain jurisdictions. By proceeding into the site or to any service of this site you confirm that you have read and understood this Legal information.
Managed Accounts for Individuals and Corporates
Market Comments
The BoD of E.ON Russia (EONR RX) adopted dividend recommendation for 2012 at R0.29 (0.92c) per share, assuming...
17.05.2013
Gazprom Neft (SIBN RX, GAZ LI) released unaudited financials under IFRS for 1Q 2013. Revenue before export duties...
16.05.2013
Novatek (NVTK RX, NVTK LI) reported strong financial results for 1Q 2013. Revenue rose by 48% y-o-y due to...
14.05.2013
Russian Sea Group (RSEA RX) posted 2012 full-year IFRS and operating results for 1Q 2013. Revenue from...
06.05.2013
FY12 consolidated results of Pharmacy Chain 36.6 (APTK RX) came below our targets on top line. Total sales decreased...
06.05.2013
Read more...
Latest Weekly since 1994
Last week’s main events in brief
Prospects for the new week
Stories to watch
Top BUY/SELL recommendations
RMG Weekly #922
Several major Russian stocks have cut-offs this week, including Gazprom, Lukoil, Surgut, VTB, Tatneft and TNK-BP Holding. This may cause a technical drop by indexes w-o-w. We see an attractive opportunity to buy ex-dividend shares.
Read more...